000			01510 a2200385 4500
005			20250514223627.0
264		0	_c20050930
008			200509s 0 0 eng d
022			_a0306-9877
024	7		_a10.1016/j.mehy.2004.09.026 _2doi
040			_aNLM _beng _cNLM
100	1		_aKurbel, Sven
245	0	0	_aSelective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers. _h[electronic resource]
260			_bMedical hypotheses _c2005
300			_a1182-7 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aBreast Neoplasms _xchemistry
650	0	4	_aCarcinoma, Ductal, Breast _xchemistry
650	0	4	_aCell Death
650	0	4	_aCell Transformation, Neoplastic
650	0	4	_aClone Cells _xdrug effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMammary Glands, Human _xchemistry
650	0	4	_aModels, Biological
650	0	4	_aMosaicism
650	0	4	_aNeoplasm Proteins _xanalysis
650	0	4	_aNeoplasms, Hormone-Dependent _xetiology
650	0	4	_aNeoplastic Stem Cells _xdrug effects
650	0	4	_aReceptors, Estrogen _xanalysis
650	0	4	_aSelection, Genetic
650	0	4	_aSelective Estrogen Receptor Modulators _xpharmacology
773	0		_tMedical hypotheses _gvol. 64 _gno. 6 _gp. 1182-7
856	4	0	_uhttps://doi.org/10.1016/j.mehy.2004.09.026 _zAvailable from publisher's website
999			_c15492665 _d15492665